Company news

Prenetics Global Limited news in 2026

Prenetics Global Limited's news releases, calls and decks from 2026, newest first.

View company

Prenetics’ IM8 Names Brian J. Rosin as Successor Chief Financial Officer

November 3, 2026

Amendment to Annual Report by Foreign Issuer (Form 20-F/A)

September 4, 2026

Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results

August 26, 2026

Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond

August 18, 2026

2Q26 Letter to Shareholders

August 18, 2026

Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference Participation

August 7, 2026

Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue

June 9, 2026

Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion

June 3, 2026

Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership

May 20, 2026

Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M

May 13, 2026

Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call

May 8, 2026

Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership

May 7, 2026

Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One

April 13, 2026

Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership

April 1, 2026

Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation

March 24, 2026

Prenetics to Participate in the 38th Annual ROTH Conference

March 18, 2026

Prenetics Authorizes $40 Million Share Repurchase Program

March 5, 2026

Prenetics Executives Execute Second Consecutive Round of Post-Earnings Open Market Share Purchases of $1.3 Million— Cumulative Personal Investment Across Both Rounds Reaches $2.7 Million

March 3, 2026

Prenetics Launches IM8 Daily Ultimate Essentials PRO — A Clinical Formula with Two New Flavours

February 22, 2026

Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity

February 18, 2026

Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY

February 18, 2026

Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors

February 17, 2026

Formula 1 Phenom Ollie Bearman Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder

February 13, 2026

Prenetics to Report Q4 and Full Year 2025 Financial Results on Feb 18, 2026 and Host Earnings Conference Call

February 11, 2026

Prenetics Provides Update on Voluntary Warrant Exchange Program, Reaching 86.7% Participation

January 5, 2026

Calls in 2026

Decks in 2026